Oncotelic Therapeutics Highlights PeerReviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted…
AV-Comparatives Validates Real-World Threat Detection in 2025 EDR XDR MDR Certification Testing
INNSBRUCK, Austria, June 15, 2025 /PRNewswire/ -- "As cyberattacks evolve, detection can't…
